Controlled Release of Matrix Metalloproteinase 1 with or without Skeletal Myoblasts Transplantation Improves Cardiac Function of Rat Hearts with Chronic Myocardial Infarction
Restricted accessResearch articleFirst published online September, 2009
Controlled Release of Matrix Metalloproteinase 1 with or without Skeletal Myoblasts Transplantation Improves Cardiac Function of Rat Hearts with Chronic Myocardial Infarction
Skeletal myoblast transplantation has been applied clinically for severe ischemic cardiomyopathy. Matrix metalloproteinase 1 (MMP-1) reduces fibrosis and prevents the progress of heart failure. We hypothesized that MMP-1 administration to the infarct area enhances the efficacy of skeletal myoblast transplantation. The controlled release of MMP-1 improved cardiac functions of rats with chronic myocardiac infarction with or without transplantation of skeletal myoblasts. Improvement in cardiac function and small fibrotic area inside the infarcted area were observed compared with those of myoblast transplantation. In conclusion, controlled release of MMP-1 was effective in cardioprotection in postmyocardial infarction although the combination with cell transplantation showed the similar effect.
Get full access to this article
View all access options for this article.
References
1.
LiR.K., MickleD.A., WeiselR.D., ZhangJ., MohabeerM.K.In vivo survival and function of transplanted rat cardiomyocytes. Circ Res, 78:283. 1996.
SakakibaraY., NishimuraK., TambaraK., YmamotoM., LuF., TabataY., KomedaM.Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg, 124:50. 2002.
4.
SakakibaraY., TambaraK., LuF., NishinaT., NagayaN., NishimuraK., KomedaM.Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction. Ann Thorac Surg, 74:25. 2002.
5.
SakakibaraY., TambaraK., LuF., NishinaT., SakaguchiG., NagayaN., NishimuraK., LiR.K., WeiselR.D., KomedaM.Combined procedure of surgical repair and cell transplantation for left ventricular aneurysm: an experimental study. Circulation, 106:I193. 2002.
6.
ChiuR.C., ZibaitisA., KaoR.L.Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg, 60:12. 1995.
7.
MurryC.E., WisemanR.W., SchwartzS.M., HauschkaS.D.Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Investig, 98:2512. 1996.
StrieterR.M.Mechanisms of pulmonary fibrosis: conference summary. Chest, 120:77S. 2001.
10.
OkazakiI., WatanabeT., HozawaS., NiiokaM., AraiM., MaruyamaK.Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery. Keio J Med, 50:58. 2001.
11.
SakaguchiG., TambaraK., SakakibaraY., OzekiM., YamamotoM., PremaratneG., LinX., HasegawaK., TabataY., NishimuraK., KomedaM.Control-released hepatocyte growth factor prevents the progression of heart failure in stroke-prone spontaneously hypertensive rats. Ann Thorac Surg, 79:1627. 2005.
12.
OzekiM., IshiiT., HiranoY., TabataY.Controlled release of hepatocyte growth factor from gelatin hydrogels based on hydrogel degradation. J Drug Target, 9:461. 2001.
13.
AoyamaT., YamamotoS., KanematsuA., OgawaO., TabataY.Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice. Tissue Eng, 9:1289. 2003.
14.
KushibikiT., TomoshigeR., FukunakaY., KakemiM., TabataY.In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. J Control Release, 90:207. 2003.
15.
FukunakaY., IwanagaK., MorimotoK., KakemiM., TabataY.Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J Control Release, 80:333. 2002.
16.
KushibikiT., MatsumotoK., NakamuraT., TabataY.Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres. Pharm Res, 21:1109. 2004.
17.
ChanH.C., RuyechanW.T., WetmurJ.G.In vitro iodination of low complexity nucleic acids without chain scission. Biochemistry, 15:5487. 1976.
18.
GreenwoodF.C., HunterW.M., GloverJ.S.The preparation of I-131-labelled human growth hormone of high specific radioactivity. Biochem J, 89:114. 1963.
19.
TambaraK., SakakibaraY., SakaguchiG., LuF., PremaratneG.U., LinX., NishimuraK., KomedaM.Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation, 108:II259. 2003.
20.
Lee-PullenT.F., BennettA.L., BeilharzM.W., GroundsM.D., SammelsL.M.Superior survival and proliferation after transplantation of myoblasts obtained from adult mice compared with neonatal mice. Transplantation, 78:1172. 2004.
21.
NishinaT., NishimuraK., YuasaS., MiwaS., NomotoT., SakakibataY., HandaN., HamanakaI., SaitoY., KomedaM.Initial effects of the left ventricular repair by plication may not last long in a rat ischemic cardiomyopathy model. Circulation, 104:I241. 2001.
22.
NishinaT., NishimuraK., YuasaS., MiwaS., SakakibaraY., IkedaT., KomedaM.A rat model of ischemic cardiomyopathy for investigating left ventricular volume reduction surgery. J Card Surg, 17:155. 2002.
23.
TambaraK., PremaratneG.U., SakaguchiG., KanemitsuN., LinX., NakajimaH., SakakibaraY., KimuraY., YamamotoM., TabataY., KomedaM.Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft. Circulation, 112:I129. 2005.
24.
ForonjyR.F., SunJ., LemaitreV., D'ArmientoJ.M.Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model. Hypertens Res, 31:725. 2008.
